SCHEMBL22981723

SCHEMBL22981723

COCc1nn(Cc2ccc3c(c2)CCN(C2CC2)C3)cc1C(=O)NCc1c(-n2cnc(C(F)F)n2)ccc(OC)c1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 10/20 1.00
▸ F11 P03951 10/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29407292 1.00 KLKB1 (1.00) KLKB1F11
SCHEMBL22982608 0.98 KLKB1 (0.95) KLKB1F11
SCHEMBL29407539 0.98 KLKB1 (0.95) KLKB1F11
SCHEMBL29406726 0.91 KLKB1 (1.00) KLKB1F11
SCHEMBL22981203 0.91 KLKB1 (1.00) KLKB1F11
SCHEMBL22982273 0.90 KLKB1 (0.82) KLKB1F11
SCHEMBL29405459 0.90 KLKB1 (0.82) KLKB1F11
SCHEMBL29697541 0.90 KLKB1 (0.82) KLKB1F11
SCHEMBL29407577 0.90 F11 (0.91) KLKB1F11
SCHEMBL29407596 0.89 F11 (1.00) KLKB1F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP disclosed
WO-2021028649-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
WO-2021028645-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
Send feedback